Marker Therapeutics, Inc. (15)

Browse by Contract Category

Contracts

Marker Therapeutics, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on August 11, 2022)
Services Agreement, effective April 12, 2022, between Wilson Wolf Manufacturing Corporation and Marker Therapeutics, Inc (Filed With SEC on April 26, 2022)
Underwriting Agreement, dated March 11, 2021 (Filed With SEC on March 16, 2021)
Exclusive License Agreement between Baylor College of Medicine and Marker Therapeutics, Inc. dated March 16, 2018 (Filed With SEC on March 15, 2019)
Sponsored Research Contract between Baylor College of Medicine and Marker Therapeutics, Inc. dated November 16, 2018 (Filed With SEC on March 15, 2019)
RSU AWARD GRANT NOTICE (2020 EQUITY INCENTIVE PLAN) (Filed With SEC on May 13, 2022)
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Marker Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on November 9, 2020)
Form of Stock Option Grant Notice and Stock Option Agreement under the Marker Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on November 9, 2020)
Description of Common Stock of Marker Therapeutics, Inc (Filed With SEC on March 12, 2020)
Registration Rights Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on March 2, 2020)
Common Stock Purchase Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on March 2, 2020)
Employment Agreement by and between Mythili Koneru and the Company dated February 6, 2019 (Filed With SEC on May 10, 2019)
Consulting Agreement between Dr. Ann Leen and Marker Therapeutics, Inc. dated October 19, 2018 (Filed With SEC on March 15, 2019)
Form of Director and Officer Indemnification Agreement (Filed With SEC on March 15, 2019)
Amendment to Employment Agreement between Marker Therapeutics, Inc. and Peter Hoang, dated March 14, 2019 (Filed With SEC on March 15, 2019)